Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-22

Clinical Trial Update: B-Complex: A Nutraceutical SANS Countermeasure [Phase 1]

View source ↗

Summary

Phase 1 trial assessing a B-Complex nutraceutical as a countermeasure for spaceflight-associated neuro-ocular syndrome (SANS). The study targets optic disc edem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • B-Complex nutraceutical (B-complex vitamins)

Snippet

Sponsor: National Aeronautics and Space Administration (NASA) | Conditions: Optic Disc Edema, Endothelial Dysfunction | Phase 1 | Status: RECRUITING